Phase 2, single-center, placebo-controlled study of the effects of combined administration of vasopressin, methylprednisolone, and epinephrine during cardiopulmonary resuscitation on survival after cardiac arrest
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Epinephrine (Primary) ; Vasopressin (Primary) ; Hydrocortisone; Hydrocortisone sodium succinate; Methylprednisolone; Methylprednisolone sodium succinate
- Indications Heart arrest
- Focus Therapeutic Use
- 12 Jan 2016 Biomarkers information updated
- 12 Jan 2009 Results reported in Archives of Internal Medicine, 12 Jan 2009.
- 06 Jan 2007 New trial record.